Seattle Institute For Biomedical And Clinical Research is located in Seattle, WA. The organization was established in 1990. According to its NTEE Classification (H92) the organization is classified as: Biomedicine & Bioengineering Research, under the broad grouping of Medical Research and related organizations. As of 09/2022, Seattle Institute For Biomedical And Clinical Research employed 153 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Seattle Institute For Biomedical And Clinical Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2022, Seattle Institute For Biomedical And Clinical Research generated $19.5m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 6.5% each year. All expenses for the organization totaled $18.6m during the year ending 09/2022. While expenses have increased by 5.3% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO IMPROVE THE HEALTH AND WELL-BEING OF VETERANS THROUGH RESEARCH AND EDUCATION CONDUCTED AT THE VA PUGET SOUND HEALTH CARE SYSTEM AND THE MANN-GRANDSTAFF VA MEDICAL CENTER. SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH (SIBCR) STRIVES TO PROVIDE OUTSTANDING SUPPORT TO VA STAFF IN THEIR RESEARCH, EDUCATION AND TRAINING ENDEAVORS AND TO FOSTER PROGRESS IN BIOMEDICAL, CLINICAL, REHABILITATIVE AND HEALTH CARE SERVICES. SIBCR PROGRAMS BENEFIT THE NATION'S VETERANS AND THE GENERAL PUBLIC.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SUPPORTED COMPLETELY, OR IN PART, ONGOING RESEARCH PROJECTS AND PROGRAMS IN OVER 30 AREAS OF RESEARCH SOME OF WHICH INCLUDE DIABETES PREVENTION, CONTROL AND PATHOPHYSIOLOGY; GERIATRIC RESEARCH AND ALZHEIMER'S DISEASE; PARKINSON'S DISEASE; MENTAL HEALTH, INCLUDING POST-TRAUMATIC STRESS DISORDER AND MILD TRAUMATIC BRAIN INJURY; INHERITED NEUROLOGICAL DISORDERS; ONCOLOGY RESEARCH; ENDOCRINE DYSFUNCTION; PULMONARY AND CARDIOVASCULAR DISEASES; SUBSTANCE ABUSE; AND REHABILITATIVE AND PROSTHETICS RESEARCH. THE BIOMEDICAL AND CLINICAL RESEARCH ENDEAVORS SUPPORTED BY THE INSTITUTE BENEFIT THE VETERAN POPULATION AND SOCIETY AT LARGE.
THE INSTITUTE HAS PROVIDED INTRAMURAL FUNDS TO INVESTIGATORS FOR PILOT OR NOVEL RESEARCH PROJECTS. SOME OF THE PROJECTS FUNDED INCLUDE RESEARCH IN BASIC AND CLINICAL NEUROSCIENCE.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Alvin Matsumoto MD President | OfficerTrustee | 2 | $0 |
Smitha Dante JD Secretary | OfficerTrustee | 1 | $0 |
Michael Tadych Fache Director | Trustee | 1 | $0 |
Catherine Kaminetzky MD MPH Director | Trustee | 1 | $0 |
William Banks MD Director | Trustee | 1 | $0 |
Robert Oh MD MPH Director | Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Spectrum Research Data/project Management | 9/29/16 | $100,016 |
Arusha Control Prosthetic Device | 9/29/16 | $116,755 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $2,141,301 |
Government grants | $15,183,516 |
All other contributions, gifts, grants, and similar amounts not included above | $2,173,814 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $19,498,631 |
Total Program Service Revenue | $0 |
Investment income | $41,794 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $19,540,425 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $462,059 |
Compensation of current officers, directors, key employees. | $462,059 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $6,442,268 |
Pension plan accruals and contributions | $427,643 |
Other employee benefits | $1,272,671 |
Payroll taxes | $542,383 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $79,415 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $204,123 |
Advertising and promotion | $11,974 |
Office expenses | $280,612 |
Information technology | $236,309 |
Royalties | $0 |
Occupancy | $108,646 |
Travel | $65,236 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $26,684 |
Conferences, conventions, and meetings | $52,160 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $187,758 |
Insurance | $58,140 |
All other expenses | $0 |
Total functional expenses | $18,558,179 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,575,245 |
Savings and temporary cash investments | $9,803,176 |
Pledges and grants receivable | $4,484,626 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $68,973 |
Net Land, buildings, and equipment | $738,496 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $14,276 |
Total assets | $16,684,792 |
Accounts payable and accrued expenses | $2,288,351 |
Grants payable | $0 |
Deferred revenue | $2,460,175 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $53,372 |
Total liabilities | $4,801,898 |
Net assets without donor restrictions | $11,289,763 |
Net assets with donor restrictions | $593,131 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $16,684,792 |
Organization Name | Assets | Revenue |
---|---|---|
Gary And Mary West Health Institute La Jolla, CA | $15,616,066 | $21,241,141 |
Washington Research Foundation Seattle, WA | $331,486,319 | $40,434,478 |
Seattle Institute For Biomedical And Clinical Research Seattle, WA | $16,684,792 | $19,540,425 |
Fogarty Institute For Innovation Mountain View, CA | $21,350,391 | $2,939,436 |
Sens Foundation Inc Mountain View, CA | $28,441,155 | $30,218,866 |